Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Key developments in non-metastatic and metastatic hormone-sensitive prostate...
Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria...
Key developments in non-metastatic and metastatic hormone-sensitive prostate cancer ( Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De Santis )
4 Jun 2018
Daratumumab in combination with carfilzomib and dexamethasone for relapsed...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Prof Karim Fizazi and Dr Neal Shore
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics ( Prof Karim Fizazi and Dr Neal Shore )
4 Jun 2018
ASCO 2018: Latest developments in non-metastatic and metastatic castration...
Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resistant prostate cancer ( Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik )
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Immunotherapy trials and hyperprogressive disease
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Immunotherapy trials and hyperprogressive disease ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
2 Jun 2018
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation